The company said third-quarter earnings per share were $4.16 on revenue of $29.4 billion. Analysts anticipated earnings per ...

Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Humana (HUM) to $290 from $387 and keeps an Overweight rating on ...

Financial writer discusses Humana's premarket drop due to Cigna's share repurchase plans, impacting ...

TD Cowen raised the firm’s price target on Humana (HUM) to $268 from $261 and keeps a Hold rating on the shares. The firm said the ...

Humana has faced a series of shocks this year, including surprise jumps in expenses and a deterioration in crucial Medicare ...

Resource specialist MJ Ryan answers calls at the Arden Hills office of Trellis, a nonprofit that's one of several groups across the state that field Senior LinkAge Line calls on Thursday. (Glen Stubbe ...

The insurer said it doesn’t expect earnings growth next year due to significant investments it plans to make to boost MA ...

Humana’s earnings beat Wall Street expectations, but the insurer said 2025 results might come in lower than analysts project, ...

Humana updated its outlook for the year thanks to a third quarter in which it beat the Street on both earnings and revenue. | Humana updated its outlook for the year thanks to a third quarter in which ...

Humana Inc.’s stock rose 1.2% premarket Wednesday after the health insurer topped third-quarter profit and revenue estimates and tweaked its guidance. Louisville, Ky.-based Humana had net income of ...

Humana (NYSE:HUM) quickly fell 5% in premarket trading at least party amid some Cigna (CI) comments about share repurchases.

Humana Inc. issued a more optimistic 2024 forecast after third-quarter profit exceeded expectations, breaking with larger peers that have struggled to contain medical costs.